Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib Extension Study in Kidney Transplant Recipients
NCT00658359Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2008
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of tofacitinib in kidney transplant rejection, sponsored by Pfizer. Started Aug 2008; status: completed.
02
Drugs
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00658359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00658359.